Yamamoto N, Naraparaju V R
Laboratory of Cancer Immunology and Molecular Biology, Albert Einstein Cancer Center, Philadelphia, PA 19141, USA.
Immunology. 1996 Aug;88(4):604-10. doi: 10.1046/j.1365-2567.1996.d01-684.x.
Macrophages were activated by administration of an inflammatory lipid metabolite, lysophosphatidylcholine (lyso-Pc), to wild type mice but not murine (microphthalmic) osteopetrotic (mi/mi) mutant mice. In vitro treatment of wild type mouse peritoneal cells with lyso-Pc efficiently activated macrophages whereas lyso-Pc-treatment of mi mutant mouse peritoneal cells resulted in no activation of macrophages. Generation of macrophage activating factor requires a precursor protein, serum vitamin D binding protein (DBP), and participation of lyso-Pc-inducible beta-galactosidase of B lymphocytes. Lyso-Pc-inducible beta-galactosidase of B lymphocytes was found to be defective in mi mutant mice.
通过向野生型小鼠注射炎性脂质代谢产物溶血磷脂酰胆碱(lyso-Pc)可激活巨噬细胞,但对小鼠(小眼症)骨石化(mi/mi)突变小鼠无效。用lyso-Pc体外处理野生型小鼠腹膜细胞可有效激活巨噬细胞,而用lyso-Pc处理mi突变小鼠腹膜细胞则不会激活巨噬细胞。巨噬细胞激活因子的产生需要一种前体蛋白,即血清维生素D结合蛋白(DBP),以及B淋巴细胞中lyso-Pc诱导的β-半乳糖苷酶的参与。发现mi突变小鼠中B淋巴细胞的lyso-Pc诱导β-半乳糖苷酶存在缺陷。